Cargando…

High mesothelin correlates with chemoresistance and poor survival in epithelial ovarian carcinoma

The objective of this paper is to investigate the mesothelin expression level to the clinicopathological features, chemoresponse, and to the outcome of patients with epithelial ovarian carcinoma (EOC). Mesothelin mRNA was detected by real-time quantitative reverse-transcription PCR in 139 EOC patien...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cheng, W-F, Huang, C-Y, Chang, M-C, Hu, Y-H, Chiang, Y-C, Chen, Y-L, Hsieh, C-Y, Chen, C-A
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2009
Materias:	Molecular Diagnostics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2669998/ https://www.ncbi.nlm.nih.gov/pubmed/19293794 http://dx.doi.org/10.1038/sj.bjc.6604964

Ejemplares similares

Luminal membrane expression of mesothelin is a prominent poor prognostic factor for gastric cancer
por: Einama, T, et al.
Publicado: (2012)

Overexpression of β2-microglobulin is associated with poor survival in patients with oral cavity squamous cell carcinoma and contributes to oral cancer cell migration and invasion
por: Chen, C-H, et al.
Publicado: (2008)

Expression of Twist increases the risk for recurrence and for poor survival in epithelial ovarian carcinoma patients
por: Hosono, S, et al.
Publicado: (2007)

High bone marrow angiopoietin-1 expression is an independent poor prognostic factor for survival in patients with myelodysplastic syndromes
por: Cheng, C-L, et al.
Publicado: (2011)

Enhanced expression of peroxisome proliferator-activated receptor gamma in epithelial ovarian carcinoma
por: Zhang, G Y, et al.
Publicado: (2005)

Creation of immortalised epithelial cells from ovarian endometrioma
por: Bono, Y, et al.
Publicado: (2012)

Viral hepatitis-associated intrahepatic cholangiocarcinoma shares common disease processes with hepatocellular carcinoma
por: Lee, C H, et al.
Publicado: (2009)

Role of multidrug resistance protein 2 (MRP2) in chemoresistance and clinical outcome in oesophageal squamous cell carcinoma
por: Yamasaki, M, et al.
Publicado: (2011)

Identification of chemoresistant factors by protein expression analysis with iTRAQ for head and neck carcinoma
por: Nishimura, K, et al.
Publicado: (2014)

Overexpression of stathmin in oral squamous-cell carcinoma: correlation with tumour progression and poor prognosis
por: Kouzu, Y, et al.
Publicado: (2006)

C-Fos expression is a molecular predictor of progression and survival in epithelial ovarian carcinoma
por: Mahner, S, et al.
Publicado: (2008)

Immunostaining of thymidylate synthase and p53 for predicting chemoresistance to S-1/cisplatin in gastric cancer
por: Kamoshida, S, et al.
Publicado: (2007)

Identification of differentially expressed genes according to chemosensitivity in advanced ovarian serous adenocarcinomas: expression of GRIA2 predicts better survival
por: Choi, C H, et al.
Publicado: (2012)

Ovarian cancer stem-like side-population cells are tumourigenic and chemoresistant
por: Hu, L, et al.
Publicado: (2010)

BubR1 as a prognostic marker for recurrence-free survival rates in epithelial ovarian cancers
por: Lee, Y-K, et al.
Publicado: (2009)

Identification and analysis of tumour-associated antigens in hepatocellular carcinoma
por: Shi, Y-Y, et al.
Publicado: (2005)

ASPM and microcephalin expression in epithelial ovarian cancer correlates with tumour grade and survival
por: Brüning-Richardson, A, et al.
Publicado: (2011)

Overexpression of glypican-1 implicates poor prognosis and their chemoresistance in oesophageal squamous cell carcinoma
por: Hara, Hisashi, et al.
Publicado: (2016)

Activation of Wnt/β-catenin signalling pathway induces chemoresistance to interferon-α/5-fluorouracil combination therapy for hepatocellular carcinoma
por: Noda, T, et al.
Publicado: (2009)

Human papillomaviral load changes in low-grade squamous intraepithelial lesions of the uterine cervix
por: Ho, C-M, et al.
Publicado: (2006)

Expression of steroid receptor coactivator 3 in ovarian epithelial cancer is a poor prognostic factor and a marker for platinum resistance
por: Palmieri, C, et al.
Publicado: (2013)

Erythrocyte sedimentation rate and anaemia are independent predictors of survival in patients with clear cell renal cell carcinoma
por: Choi, Y, et al.
Publicado: (2013)

Downregulated miR-646 in clear cell renal carcinoma correlated with tumour metastasis by targeting the nin one binding protein (NOB1)
por: Li, W, et al.
Publicado: (2014)

Downregulation of HLA Class I molecules in the tumour is associated with a poor prognosis in patients with oesophageal squamous cell carcinoma
por: Mizukami, Y, et al.
Publicado: (2008)

Tumour-associated macrophages correlate with poor prognosis in myxoid liposarcoma and promote cell motility and invasion via the HB-EGF-EGFR-PI3K/Akt pathways
por: Nabeshima, A, et al.
Publicado: (2015)

MiR-224 promotes the chemoresistance of human lung adenocarcinoma cells to cisplatin via regulating G(1)/S transition and apoptosis by targeting p21(WAF1/CIP1)
por: Wang, H, et al.
Publicado: (2014)

Prognostic significance of epithelial–mesenchymal transition-related markers in extrahepatic cholangiocarcinoma: comprehensive immunohistochemical study using a tissue microarray
por: Nitta, T, et al.
Publicado: (2014)

Co-expression of RON and MET is a prognostic indicator for patients with transitional-cell carcinoma of the bladder
por: Cheng, H-L, et al.
Publicado: (2005)

hTERT phosphorylation by PKC is essential for telomerase holoprotein integrity and enzyme activity in head neck cancer cells
por: Chang, J T, et al.
Publicado: (2006)

TSPY is a cancer testis antigen expressed in human hepatocellular carcinoma
por: Yin, Y-H, et al.
Publicado: (2005)

Tissue microarray analysis of human FRAT1 expression and its correlation with the subcellular localisation of β-catenin in ovarian tumours
por: Wang, Y, et al.
Publicado: (2006)

Expression of CIP2A in renal cell carcinomas correlates with tumour invasion, metastasis and patients’ survival
por: Ren, J, et al.
Publicado: (2011)

The chemokine, CXCL12, is an independent predictor of poor survival in ovarian cancer
por: Popple, A, et al.
Publicado: (2012)

Overexpression of nucleostemin contributes to an advanced malignant phenotype and a poor prognosis in oral squamous cell carcinoma
por: Yoshida, R, et al.
Publicado: (2014)

Cancer-associated fibroblasts induce epithelial–mesenchymal transition of breast cancer cells through paracrine TGF-β signalling
por: Yu, Y, et al.
Publicado: (2014)

STAT3 upregulates miR-92a to inhibit RECK expression and to promote invasiveness of lung cancer cells
por: Lin, H-Y, et al.
Publicado: (2013)

Id-1 and Id-2 are markers for metastasis and prognosis in oesophageal squamous cell carcinoma
por: Yuen, H-F, et al.
Publicado: (2007)

Thrombomodulin expression in colorectal carcinoma is protective and correlates with survival
por: Hanly, A M, et al.
Publicado: (2006)

BCAS2 promotes prostate cancer cells proliferation by enhancing AR mRNA transcription and protein stability
por: Kuo, P-C, et al.
Publicado: (2015)

High FoxP3 expression in tumour cells predicts better survival in gastric cancer and its role in tumour microenvironment
por: Ma, G-F, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_rcf03njmh203rloa71fnbg4o7c